Impact of Smoking on the Development of Idiopathic Pulmonary Fibrosis: Results From a Nationwide Population-Based Cohort Study

Authors: Kyung Do HanChang Hoon LeeWon C BaeJinwoo LeeSun Mi ChoiYoung Whan Kim
Year: 2021
Times cited: 1

Key People For Idiopathic Pulmonary

Top KOLs in the world
Moises * ******
idiopathic pulmonary fibrosis hypersensitivity pneumonitis epithelial cells
Talmadge * ****
idiopathic pulmonary fibrosis patients ipf alveolar macrophages
Ganesh * *****
idiopathic pulmonary fibrosis interstitial lung disease patients ipf
Luca ********
idiopathic pulmonary fibrosis inpulsis trials patients ipf
Harold * *******
idiopathic pulmonary fibrosis acute exacerbation interstitial lung disease
Annie *****
idiopathic pulmonary fibrosis hypersensitivity pneumonitis epithelial cells

Impact of smoking on the development of idiopathic pulmonary fibrosis: results from a nationwide population-based cohort study


BACKGROUND: Smoking has been considered an important risk factor for idiopathic pulmonary fibrosis (IPF) incidence. However, there are no population-based large-scale studies demonstrating the effects of smoking on the development of IPF. We aimed to evaluate the effect of smoking on IPF development using a nationwide population-based cohort.

METHODS: Using the Korean National Health Information Database, we enrolled individuals who had participated in the health check-up service between 2009 and 2012. Participants having a prior diagnosis of IPF were excluded. The history of smoking status and quantity was collected by a questionnaire. We identified all cases of incident IPF through 2016 on the basis of ICD-10 codes for IPF and medical claims. Cox proportional hazards models were used to calculate the adjusted HR (aHR) of the development of IPF.

RESULTS: A total of 25 113 individuals (0.11%) with incident IPF were identified out of 23 242 836 participants registered in the database. The risk of IPF was significantly higher in current and former smokers than in never smokers, with an aHR of 1.66 (95% CI 1.61 to 1.72) and 1.42 (95% CI 1.37 to 1.48), respectively. Current smokers had a higher risk of IPF than former smokers (aHR 1.17, 95% CI 1.13 to 1.21). The risk of IPF development increased as the smoking intensity and duration increased.

CONCLUSION: Smoking significantly increased the risk of IPF development. Current smokers had a higher risk of IPF than former smokers. A dose-response relationship was observed between smoking and the development of IPF.

to see all concepts, it's free!